# Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

> **NCT03661034** · NA · UNKNOWN · sponsor: **Cognito Therapeutics, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Alzheimer Disease, Early Onset
- Alzheimer Disease
- Alzheimer Dementia
- Mild Cognitive Impairment
- Memory Disorders
- Memory Loss
- Memory Impairment
- Memory Disorders, Age Related
- Alzheimer Disease, Late Onset
- Cognitive Impairment
- Dementia, Mild
- Dementia, Alzheimer Type
- Cognitive Decline

## Interventions

- **DEVICE:** GammaSense Stimulation System (non-invasive, non-significant risk)

## Key facts

- **NCT ID:** NCT03661034
- **Lead sponsor:** Cognito Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-31
- **Primary completion:** 2021-05-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03661034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03661034, "Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03661034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*